Menopause

Menopause
Audio Summaries

Menopause (New York, N.Y.)

Every issue of Menopause moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.

264 audio summariesNLM Catalog

Specialties

Menopause covers research in these specialties.

Recent summaries

The latest articles summarized from Menopause.

Updated clinical recommendations for cardiovascular risk assessment to facilitate hormone therapy prescribing: incorporating PREVENT risk calculator and the 2026 multisociety lipid guidelines.

Nov 17, 2026

This perspective asks how clinicians can integrate cardiovascular risk assessment, using the newly introduced PREVENT calculator and the 2026 multisociety lipid guideline, into decisions about menopausal hormone therapy (HT). The authors propose a practical framework that stratifies women by PREVENT-derived 10- and 30-year risk, incorporates coronary artery calcium scoring and female-specific risk enhancers, and aligns lipid management targets with HT initiation and route of administration. Their goal is to help clinicians individualize HT decisions for symptomatic midlife women while optimizing cardiovascular risk reduction.

Bilateral oophorectomy after natural menopause and prevalent cardiometabolic and skeletal outcomes in US women: a cross-sectional NHANES analysis.

Nov 17, 2026

This cross-sectional study of pooled NHANES data (1999-2018) asked whether bilateral oophorectomy after natural menopause is linked to cardiometabolic and skeletal conditions in US women, comparing 321 women with oophorectomy to 5,363 naturally menopausal referents. Women with oophorectomy had a higher prevalence of self-reported cardiovascular disease (prevalence ratio 1.58), which remained significant after false discovery rate correction, while associations with diabetes, hypertension, osteoporosis, and wrist fracture were not statistically robust, and hip and spine fractures could not be estimated. Because the design is cross-sectional with no outcome timing and possible residual confounding, the findings indicate an association only and do not support causal conclusions or clinical recommendations.

Body composition and mortality across the reproductive cycle: findings from the Multi-Ethnic Study of Atherosclerosis.

Nov 17, 2026

This study examined whether fat mass (FM) and fat-free mass (FFM), estimated from bioelectrical impedance, are associated with major adverse cardiovascular events (MACE) and total mortality across reproductive stages in 3,439 women from the Multi-Ethnic Study of Atherosclerosis. Across the full cohort, higher FM was linked to greater risk of MACE and mortality, while higher FFM was linked to lower mortality, with the strongest mortality associations seen during the menopause phase. Because these associations were absent in similarly aged women who had not yet reached menopause, the authors suggest that ovarian aging may modify how body composition relates to long-term health outcomes.

Phenotypic age acceleration mediates the association between plant-based diet and advanced cardiovascular-kidney-metabolic syndrome among postmenopausal women: a population-based cross-sectional analysis.

Nov 17, 2026

This cross-sectional study of 2,988 postmenopausal women from NHANES 2005-2018 asked whether plant-based dietary indices are linked to advanced cardiovascular-kidney-metabolic (CKM) syndrome and whether biological aging explains that link. Higher overall and healthful plant-based diet scores were associated with lower odds of advanced CKM, while higher unhealthful plant-based diet scores were associated with higher odds. Phenotypic age acceleration partially mediated the association between plant-based diet index and advanced CKM, accounting for about 16% of the effect.

The relationships among gender perceptions, internalized misogyny, and body shame in postmenopausal women: a structural equation modeling study.

Nov 17, 2026

This cross-sectional study of 210 postmenopausal women used structural equation modeling to examine how gender perception, internalized misogyny, and body shame relate to one another. The authors found that more egalitarian gender perceptions were associated with lower internalized misogyny and lower body shame, while greater internalized misogyny was associated with greater body shame. Because the design is cross-sectional, the findings reflect associations only and cannot establish temporal or causal relationships.

Breast cancer in premenopausal and postmenopausal women: clinicopathological findings and survival outcomes from a large registry-based cohort in Southern Iran.

Nov 17, 2026

This retrospective study of 6,930 women with breast cancer in the Shiraz Breast Cancer Registry (Iran, 2014–2022) asked how premenopausal and postmenopausal patients differ in tumor biology, treatment, and survival. Premenopausal women had more aggressive tumors (larger size, multifocality, necrosis, adverse pathology), while postmenopausal women had more estrogen receptor-positive tumors and received more hormone therapy. Five-year overall survival was similar between groups, and disease-free survival was modestly higher in postmenopausal women, but the authors conclude that menopausal status has limited independent prognostic value once age and tumor characteristics are accounted for.

Endometrial thickness and risk of endometrial pathology in women with postmenopausal bleeding: the influence of hormone therapy.

Nov 11, 2026

This study asked whether endometrial thickness (ET) reliably identifies endometrial cancer or atypical hyperplasia in postmenopausal women with vaginal bleeding, and whether menopausal hormone therapy use changes that performance. In a retrospective cohort of 1,082 women referred to an urgent cancer pathway in a UK hospital, ET showed excellent discrimination in non-users of hormone therapy (AUC 0.925) but poor discrimination in users of continuous combined therapy (AUC 0.597). The authors conclude that ET is a useful triage tool for women not on hormone therapy, while its value as a standalone measure is limited in those on continuous combined therapy, so HT status should guide interpretation and referral.

Validation of the Perimenopause Symptom Scale (Peri-SS) for digital self-assessment: psychometric evaluation among US women aged 35 to 59 years.

Nov 11, 2026

The authors asked whether a new, concise, perimenopause-specific symptom questionnaire, the Perimenopause Symptom Scale (Peri-SS), could reliably and validly measure symptom burden for digital self-assessment among US women aged 35-59. In a Prolific-based longitudinal study of 1,255 women (633 self-identified as perimenopausal), the four-domain scale (vasomotor, psychological, sexual, physical) showed strong structural validity, internal consistency (α=0.90), test-retest reliability (ICC=0.82), a high correlation with the Menopause Rating Scale (r=0.88), and responsiveness to change over time. The findings support the Peri-SS as a reliable, valid, and responsive tool for research, clinical care, and digital health use, though the reported publication date (2026) and the self-selected online sample warrant consideration.

An exploration of the physical and mental health impact among a diverse population in the United Kingdom experiencing perimenopause and menopause (MARIE UK-WP2a).

Nov 11, 2026

This prospective mixed-methods cohort study of 845 baseline and 538 follow-up UK participants (median age 52) asked how symptom burden and quality of life differ across perimenopausal, menopausal, and postmenopausal stages and by mode of onset (natural vs. surgical). The authors found that anxiety was highest in perimenopause, while depressive symptoms, insomnia, back pain, vasomotor symptoms, and reduced quality of life were most pronounced in surgical menopause, with cognitive complaints peaking in perimenopause. They conclude that symptom severity depends on menopausal stage and onset mode, supporting stage-specific clinical pathways and workplace adaptations, especially for people with conditions such as endometriosis.

Factors associated with receipt of prescription medication for menopause-related symptoms.

Oct 27, 2026

This retrospective cohort study of 5,491 women aged 40-55 at a large academic health system asked which patient and clinician factors are associated with receiving prescription medication for menopause-related symptoms. The authors found that Black women were less likely than White women to receive any prescription treatment (including systemic estrogen) but more likely to receive SSRIs, and that patients seen by internal medicine, family medicine, or endocrinology were less likely to receive treatment than those seen in OB/Gyn settings. The findings point to race-, insurance-, and specialty-related differences in menopause care that warrant efforts toward more equitable treatment.

Listen to Menopause

14-day free trial. Every new article, summarized in ~3 minutes.